As per 10th of July 2015 we are proud to have obtained our first marketing authorization in Belarus for Colistin 4800 WSP.
Colistin 4800 WSP is a water-soluble powder for oral administration for non-ruminating calves, pigs and poultry. Colistin 4800 WSP is indicated in the treatment of gastrointestinal infections caused by gram negative bacteria, especially Salmonella spp and Escherichia coli.
By having the marketing authorisation approved via the Belarus authorities, we can now start to sell in Belarus, Russia, Kazakhstan, Armenia and Kyrgyzstan. Several other files have been submitted to the authorities and we hope to soon build a portfolio from which we show a more strong presence in the Russian Federation and other former CIS countries.
We specifically want to congratulate our team in Dopharma Baltic for all their work and perseverance.
Dopharma International bv